Tcg Advisory Services, LLC Adma Biologics, Inc. Transaction History

Tcg Advisory Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$17.6 - $24.51 $50,899 - $70,882	2,892 Added 18.46%	18,560 $337,000
Q1 2025 May 15, 2025	BUY	$15.44 - $20.61 $85,784 - $114,509	5,556 Added 54.94%	15,668 $310,000
Q4 2024 Feb 11, 2025	SELL	$15.62 - $22.62 $81,817 - $118,483	-5,238 Reduced 34.12%	10,112 $173,000
Q3 2024 Nov 14, 2024	SELL	$11.21 - $20.03 $22,375 - $39,979	-1,996 Reduced 11.51%	15,350 $306,000
Q2 2024 Aug 09, 2024	SELL	$5.98 - $11.18 $3,067 - $5,735	-513 Reduced 2.87%	17,346 $193,000

Q1 2024 May 10, 2024	BUY	$4.4 - $6.74 $78,579 - $120,369	17,859 New	17,859 $117,000

401

205M

3.06M

1.88M

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.06B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Tcg Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Tcg Advisory Services, LLC with notifications on news.